Clinical Trials Sponsored by Chongqing Zhongshan Hospital

Total 1431 results

CAI Hongbing

Recruiting

A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation

Ovarian Cancer | Epithelial Ovarian Cancer | Ovarian Cancer, Epithelial | Hyperthermic Intraperitoneal Chemotherapy(HIPEC) | Homologous Recombination Repair Gene Mutation

China
Zhongming Qiu
Xiangtan Central Hospital

Not yet recruiting

Endovascular Thrombectomy for eXtra-Large Ischemic Stroke (XL STROKE)

Stroke, Acute
Zhongming Qiu
Xingguo County People's Hospital

Recruiting

DTI-guided Minimally Invasive Hematoma Evacuation for Intracerebral Hemorrhage (GLAMOR)

Stroke Hemorrhagic

China
Xinqiao Hospital of Chongqing
Chongqing Medical University

Not yet recruiting

Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer

Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer
Shanghai Zhongshan Hospital

Not yet recruiting

A Risk Prediction Model of Postoperative Nausea and Vomiting in Patients With Liver Cancer

Liver Cancer | Nausea and Vomiting, Postoperative
Shanghai Zhongshan Hospital

Recruiting

Prevalence and Affecting Factors of Sleep and Circadian Rhythm Disorders in ICU

Critical Illness | Sleep Deprivation | Circadian Rhythm Disorders

China
Shanghai Zhongshan Hospital

Not yet recruiting

Ciprofol Versus Propofol for Tracheal Intubation in ICU

Emergency Tracheal Intubation in Critically Ill Patients
Shanghai Zhongshan Hospital

Recruiting

The SLEEP-CARE Study

Sleep Disturbance

China
Shanghai Zhongshan Hospital

Recruiting

Diagnosis of HCM With AI-ECG

Hypertrophic Cardiomyopathy

China
Shanghai Zhongshan Hospital

Not yet recruiting

IVUS CHIP China Registry

Complex Higher Risk Indicated Patients Undergoing PCI
Shanghai Zhongshan Hospital

Recruiting

The Pathogenesis and Prognostic Factors of Lymphoma

Lymphoma | Hodgkin Lymphoma | Non-hodgkin Lymphoma

China
Shanghai Zhongshan Hospital

Recruiting

Efficacy of CeraVe® Moisturizing Cream on Skin Pruritus in Elderly Patients

Pruritus

China
Shanghai Zhongshan Hospital

Recruiting

Efficacy and Safety Evaluation of Fecal Microbiota Transplantation in Irritable Bowel Syndrome

Irritable Bowel Syndrome

China
Shanghai Zhongshan Hospital

Recruiting

Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma | Neoadjuvant Chemoimmunotherapy

China
Shanghai Zhongshan Hospital

Recruiting

Changes in Lung Aeration and Inspiratory Effort With and Without Awake Prone

Respiratory Distress Syndrome | Ventilation Therapy; Complications

China
Shanghai Zhongshan Hospital

Recruiting

Prone Positioning vs. Prone Positioning and NO Inhalation in COVID-19 ARDS.

Respiratory Distress Syndrome

China
Shanghai Zhongshan Hospital

Recruiting

Quick Recognition of Aortic Dissection

Aortic Dissection

China
Shanghai Zhongshan Hospital

Recruiting

The Diagnostic and Prognostic Value of Speckle Tracking Imaging in Septic Cardiomyopathy

Sepsis | Cardiomyopathies | Echocardiography

China
Shanghai Zhongshan Hospital

Recruiting

Zimberelimab Combined With Concurrent Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer

Locally Advanced Cervical Cancer

China
Shanghai Zhongshan Hospital

Recruiting

Impact of Partial Capsule Decortication on Device-related Infection in Patients Receiving Cardiac Implantable Electronic Device Replacement (STERILE)

Infections | Pacemaker Complication

China
Shanghai Zhongshan Hospital

Recruiting

Safety and Feasibility of TRISKELE in Severe AS

Aortic Valve Disease

China
Shanghai Zhongshan Hospital

Not yet recruiting

Neoadjuvant TACiE in Locally Advanced Gastric Cancer

Gastric Cancer

China
Shanghai Zhongshan Hospital

Recruiting

Lp(a) With CCTA Assessed Parameters and Clinical Outcomes (CHART-ACCORD)

Coronary Artery Disease

China
Shanghai Zhongshan Hospital

Recruiting

Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment

Helicobacter Pylori Infection

China
Shanghai Zhongshan Hospital

Not yet recruiting

Inhaled Amikacin in Preventing AECOPD

COPD | COPD Exacerbation

China
Shanghai Zhongshan Hospital

Not yet recruiting

Efficacy and Safety of Butorphanol Tartrate Injection for the Patients With Mechanical Ventilation

Analgesia | Hospital-acquired Infections
Shanghai Zhongshan Hospital

Recruiting

A Single Center Real-world Study of Donafenib in the Treatment of Hepatocellular Carcinoma in Routine Clinical Practice

Hepatocellular Carcinoma | Donafenib

China
Shanghai Zhongshan Hospital

Recruiting

Chlorhexidine Bathing to Prevent Hospital-acquired Infections: the CLEANS Study

Surgery | Intensive Care Unit | Hospital-Acquired Infection | Chlorhexidine

China
Shanghai Zhongshan Hospital

Recruiting

Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis

Takayasu Arteritis

China
Shanghai Zhongshan Hospital

Not yet recruiting

Gut Microbiota Reconstruction for NSCLC Immunotherapy

Non-Small Cell Lung Cancer

China
Shanghai Zhongshan Hospital

Recruiting

Evaluate Early Invasive Strategy for Patients With STEMI Presenting 24-48 Hours From Symptom Onset

ST-segment Elevation Myocardial Infarction (STEMI)

China
Shanghai Zhongshan Hospital

Recruiting

Anti-PD1 Antibody Toripalimab Combined With Gemox as First-line Therapy in Late-stage Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma

China
Shanghai Zhongshan Hospital

Recruiting

Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b Treatment in Patients With Advanced-Stage HCC

Hepatocellular Carcinoma

China
Shanghai Zhongshan Hospital

Recruiting

Comparison of Tofacitinib and Methotrexate in the Maintained Treatment of GPA

Granulomatosis With Polyangiitis

China
Shanghai Zhongshan Hospital

Recruiting

Toripalimab Plus Sorafenib in Patients With Advanced-Stage Hepatocellular Carcinoma (Toripalimab)

Hepatocellular Carcinoma

China
Shanghai Zhongshan Hospital

Recruiting

Evaluation of Remifentanil and Dexmedetomidine in Patients With Noninvasive Mechanical Ventilation Intolerance

NIV Intolerance

China
Shanghai Zhongshan Hospital

Recruiting

Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC

Hepatocellular Carcinoma

China
Shanghai Zhongshan Hospital

Recruiting

The Consistency of Cardiac Output Measured by Pulmonary Artery Catheter and LiDCO in Cardiac Surgical Patients

Cardiac Surgery | Cardiac Output

China
Shanghai Zhongshan Hospital

Not yet recruiting

Compare Early With Deferred Invasive Strategy for STEMI Presenting 24-48 Hours From Symptom Onset

ST-segment Elevation Myocardial Infarction (STEMI)
Shanghai Zhongshan Hospital

Not yet recruiting

The 3 Years vs 1 Year DAPT After XINSORB BRS Implantation (SPARTA)

Cardiovascular Diseases
Shanghai Zhongshan Hospital

Recruiting

A Pilot Study in Severe Patients With Takayasu Arteritis.

Takayasu Arteritis | Treatment | Tocilizumab | Adalimumab

China
Shanghai Zhongshan Hospital

Recruiting

Fruquintinib as a Maintenance Therapy Following First-line Treatment for Metastatic Colorectal Cancer

Colo-rectal Cancer

China
Shanghai Zhongshan Hospital

Recruiting

Drug-coated Balloon for Takayasu Arteritis Associated Renal Artery Stenosis

Takayasu Arteritis

China
Shanghai Zhongshan Hospital

Not yet recruiting

IVUS VS CAG Guided PCI for Patients With LMB Lesion (Infinite)

Coronary Artery Disease | Left Main Coronary Artery Disease
Shanghai Zhongshan Hospital

Recruiting

The Registry Study of Takayasu Arteritis in East China

Pregnancy Related | Takayasu Arteritis | Treatment Refusal | Outcome | Mechanisms, Defense

China
Shanghai Zhongshan Hospital

Recruiting

Modified T-Stenting With Szabo Technique Versus T-Stenting for Bifurcation Lesions in Coronary Heart Diseases

Coronary Artery Disease

China
Shanghai Zhongshan Hospital

Not yet recruiting

Enriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. Chemoradiotherapy

Gastric Cancer

China
Shanghai Zhongshan Hospital

Completed

Comparison of UFR With QFR in Stable Coronary Artery Disease

Coronary Artery Disease

China
Shanghai Zhongshan Hospital

Active, not recruiting

Pembrolizumab and Lenvatinib for Resectable Hepatocellular Carcinoma (NeoLeap-HCC)

Carcinoma, Hepatocellular

China
Shanghai Zhongshan Hospital

Completed

Glucocorticoids for Post-operative Patients With Acute Type A Aortic Dissection (The GLAD Trial)

Methylprednisolone | Aortic Dissection | Organ Dysfunction | Glucocorticoid

China

Clinical Trials Sponsored by Chongqing Zhongshan Hospital

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations